Changes in Immunological Parameters in Patients with Opium Abuse Receiving ANAR Therapy

Bulletin of Experimental Biology and Medicine

Volumn 135-136, Issue 7, 2003, Pages 189-191

  Vetlugina, T P ^a   Ivanova, S A ^a   Bokhan, N A ^a   Epstein, O I ^b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b Materia Medica Holding R   (Russian Federation)

Author keywords

Antibodies to morphine; Immune system; Opium abuse; Ultralow doses

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; DOPAMINE RECEPTOR; HLA DR ANTIGEN; HUMORAL ANTIBODY; IMMUNOGLOBULIN; MORPHINE; OPIATE; PROTEIN ANAR; PROTEIN ANTIBODY; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM; DRUG EFFECT; HUMAN; IMMUNOLOGICAL PARAMETERS; IMMUNOMODULATION; LYMPHOCYTE; OPIATE ADDICTION;

EID: 0347003464     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024717216301     Document Type: Article

References (18)

1. N. A. Aliev, Immunologiya, No. 1, 7-11 (1989).
2. I. P. Anolhina, Vestn. Akad. Med. Nauk SSSR, No. 3, 21-27 (1988).
3. I. P. Anolhina, N. N. Ivanets, and V. Ya. Drobysheva, Vestn. Ros. Akad. Med. Nauk, No. 7, 29-37 (1998).
4. N. A. Bokhan, T. P. Vetlugina, and A. I. Mandel', Sibirsk. Vestn. Psikhiatr. Narkol., No. 1, 15-22 (2002).
5. T. P. Vetlugina, S. A. Ivanova, V. Ya. Semke, and N. A. Kornetov, Byull. Eksp. Biol. Med., 129, Appl. 1, 47-50 (2000).
6. T. P. Vetlugina, Sibirsk. Vestn. Psikhiatr. Narkol., No. 1. 110-111 (2002).
7. N. B. Gamaleya, L. I. Ul'nova, I. D. Darenskii, et al., Vopr. Narkol., No. 4, 54-60 (2000).
8. L. V. Devoino and R. Yu. Il'yuchenok, Neuromediator Systems in Psychoneuroimmunomodulation [in Russian], Novosibirsk (1993).
9. V. A. Evseev, Immunologiya, No. 2, 4-8 (1990).
10. S. A. Ivanova, Psychoneuroimmunomodulation in Clinics and Therapy of Neurotic and Affective Disorders, Abstract of Doct. Med. Sci. Dissertation, Tomsk (2000).
11. S. A. Ivanova, T. P. Vetlugina, N. A. Bokhan, and O. I. Epstein, Sibirsk. Vestn. Psikhiatr. Narkol., No. 1, 52-60 (2002).
12. L. F. Panchenko, S. G. Morozov, M. I. Sokur, and T. Yu. Dorodnykh, Vopr. Narkol., No. 4, 45-47 (1995).
13. R. V. Petrov, R. M. Khaitov, B. V. Pinegin, and I. V. Oradovskaya, Immunologiya, No. 4, 51-62 (1992).
14. K. D. Pletsityi and T. V. Davydova, Itogi Nauki Tekhniki VINITI. Ser. Immunologiya, 20, 4-38 (1989).
15. O. I. Epstein, Byull. Sib. Otd. Ros. Akad. Med. Nauk, No. 1 (91), 132-149 (1999).
16. O. I. Epstein, VII Russian National Congress "Human and Medicine". Symposium "Ultralow Doses of Psychotropic Preparations", Moscow (2000), Abstracts of Papers, pp. 11-21.
17. V. V. Yushkov and T. A. Yushkova, Modern Problems of Clinical and Experimental Psychoneuroimmunology [in Russian], Tomsk (1992), Vol. 1, pp. 138-140.
18. V. Haskova, I. Kaslik, J. Riha, et al., Z. Immun-Forsch., 154, 399-406 (1978).